Semaglutide
medicationA GLP-1 medication that reduces appetite, approved for weight management and type 2 diabetes.
Metformin is a medication that is FDA-approved, prescription only.
Also known as Glucophage, Glumetza, Fortamet
Metformin is a first-line medication for type 2 diabetes that lowers the liver's glucose output. It is sometimes prescribed off-label for prediabetes or weight, and it is widely discussed as a potential longevity drug, which has not been proven.

Approved by the FDA. A licensed clinician has to decide it is right for you and prescribe it. FDA-approved prescription drug for type 2 diabetes. Use for weight, prediabetes or aging is off-label and at a clinician's discretion.
As of September 23, 2026.
Key takeaways
Metformin lowers blood sugar mainly by reducing how much glucose your liver releases. It also cuts the glucose absorbed from your gut and helps your muscles use insulin better.
It does not make your pancreas release more insulin, so on its own it rarely causes low blood sugar.



Strong evidence for blood sugar control and for delaying type 2 diabetes in high-risk adults (Diabetes Prevention Program); weight effects are modest and longevity benefits are unproven in humans.
What trials and prescribing information measured over time. Everyone responds differently.
Diarrhea, nausea and stomach upset are the most common side effects and are most likely early on.
In the Diabetes Prevention Program, the reduction in diabetes risk was measured over about three years.
In the long-term follow-up, metformin still delayed diabetes by about 18% compared with placebo at 15 years.
Clinicians consider metformin a proven, low-cost drug for diabetes and diabetes prevention in high-risk adults. Its use for weight or longevity is off-label and less supported.
The ADA Standards of Care say metformin should be considered to prevent type 2 diabetes in high-risk adults with prediabetes, especially those under 60, with a BMI of 35 or more, or with a history of gestational diabetes.
ADA Standards of Care 2026, Section 3: Prevention or delay of diabetesIn the NIH-funded Diabetes Prevention Program, metformin cut the risk of developing type 2 diabetes by 31% and an intensive lifestyle program by 58%, compared with placebo, over about three years.
NIDDK: Diabetes Prevention Program (DPP)The USPSTF recommends screening adults aged 35 to 70 with overweight or obesity for prediabetes and type 2 diabetes, and notes lifestyle programs outperformed metformin for prevention.
USPSTF: Screening for prediabetes and type 2 diabetes (2021)The metformin label carries a boxed warning for lactic acidosis, a rare but serious complication, with higher risk in kidney or liver impairment, heavy alcohol use and around contrast imaging.
DailyMed: Metformin prescribing informationSummaries of published guidelines, drug labels, regulators and reviews, each attributed to its source. DiscoverMedica does not employ clinicians.
Only a licensed clinician who knows your history can decide whether it is right for you.
These save with the compound when you add it to My Journal, so they’re on the printout for your visit.

Complete an online health questionnaire, including your kidney health and other medications.
A licensed clinician reviews it, usually asynchronously.
Labs may be requested: at minimum, a kidney function test before starting.
If prescribed, the pills ship to you or go to a local pharmacy. Generic metformin is inexpensive.
Check in periodically for kidney function and, over time, vitamin B12.
Some services let you order common lab tests yourself, so the results are ready for your visit. Your clinician decides which labs, if any, you need, and what the results mean.
From each service’s own site, checked September 23, 2026.
From each provider’s own site, checked September 23, 2026. Programs change, so confirm the details before you sign up.
12 providers list Metformin on DiscoverMedica, lowest listed price first.
† Prices as listed by the provider when we checked; they change.
Listed prices run from $15 to $99 a month across 6 providers, as checked October 7, 2026.
Prices as listed by the provider when we checked; they change. Membership or consult fees may be separate; see each provider.
Modestly, for some people. It is not approved for weight loss, and average weight change in studies is small compared with GLP-1 drugs.
That has not been shown in people. It is being studied, but longevity use is off-label and unproven.
GI side effects are common at the start. Clinicians often use extended-release forms or start low to reduce them. Talk to your prescriber rather than adjusting on your own.
The label lists low vitamin B12 as a possible effect of long-term use, so periodic checks are common.
Yes. Several telehealth providers prescribe it, and mail-order pharmacies fill it.
This is not a complete list of risks. Read the full prescribing information and any Medication Guide, and talk to a licensed clinician or pharmacist about your own situation. If you have a severe reaction, call 911. You can report side effects to the FDA through MedWatch at 1-800-FDA-1088.
Guide reviewed September 23, 2026.
Educational information only, not medical advice. It does not replace a conversation with a licensed clinician.
A GLP-1 medication that reduces appetite, approved for weight management and type 2 diabetes.
A weekly GIP and GLP-1 medication approved for weight management, sleep apnea and type 2 diabetes.
An older, daily GLP-1 injection for weight management and diabetes, now available as a generic.
An investigational triple-hormone weight-loss drug from Eli Lilly. Not approved; only available in trials.